LES INHIBITEURS DES TYROSINES KINASES
| dc.contributor.advisor | A. IBRAHIMI | |
| dc.contributor.author | Kenza OUARDA | |
| dc.date.accessioned | 2025-02-21T12:22:41Z | |
| dc.date.accessioned | 2025-12-17T09:57:42Z | |
| dc.date.available | 2025-02-21T12:22:41Z | |
| dc.date.issued | 2017 | |
| dc.description.collaborator | J. EL HARTI | |
| dc.description.collaborator | S. BENKIRANE | |
| dc.description.collaborator | R. NEJJARI | |
| dc.identifier.uri | https://toubkal.imist.ma/handle/123456789/36396 | |
| dc.identifier.uri | https://doi.org/10.83129/toubkal-8026 | |
| dc.language.iso | fr | |
| dc.publisher | Faculté de Médecine et de Pharmacie, Rabat - Thèse de médecine | fr_FR |
| dc.subject | Inhibiteurs des tyrosines kinases | fr_FR |
| dc.subject | Thérapie ciblée | fr_FR |
| dc.subject | Cancer | fr_FR |
| dc.subject | Voies de signalisation | fr_FR |
| dc.subject.ddc | 616.99 | |
| dc.subject.other | Biotechnologie | |
| dc.subject.specific | Thérapie ciblée en cancérologie | |
| dc.title | LES INHIBITEURS DES TYROSINES KINASES | fr_FR |
Files
Original bundle
1 - 1 of 1